A- A A+
Last Updated : Jan 18 2021 6:41PM     Screen Reader Access
News Highlights
PM Modi lays foundation stone of environment friendly Ahmedabad Metro Rail Project Phase-II and Surat Metro Rail Project            National COVID-19 recovery rate improves to 96.59 per cent            Over 2 lakh people vaccinated for Covid-19 across country during past two days            Britain invites PM Modi to attend G7 Summit to be held in June this year            Brisbane Test: Australia bundled out for 294 on day 4           

Jul 07, 2020
9:07PM

Mylab Discovery Solutions launches India’s first machine to automate manual processes of molecular diagnostic tests

@MylabSolutions
Pune-based molecular diagnostics company, Mylab Discovery Solutions has launched ‘Compact XL’ - India’s first machine to automate the manual processes of molecular diagnostic tests such as RT-PCR tests for Covid-19.
 
Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing RT-PCR ready tubes. It is a cartridge-based machine and can test multiple samples at the same time. It can be used for a wide range of RNA/DNA-based tests including Covid-19 RT-PCR tests. The machine can take input of various sample types such as plasma, tissue, sputum and swab.
 
Speaking about the benefits of this 100 per cent indigenously developed machine, Hasmukh Rawal, MD, Mylab Discovery Solutions said that Compact XL is their most ambitious project so far to make India self-reliant in advanced diagnostics. Compact XL will replace the need of 700 sq ft of clean room lab with a 4x3 benchtop machine and reduce the need of 3-4 expert technicians to just one, saving operational costs for labs. From patients’ perspective, automated processes will eliminate errors and improve accuracy, for example, the robotic movements in machine are precise to the tune of hundred-thousandths of a ml when handling liquids. This machine will ensure that DNA/RNA test such as Covid-19 testing can be done without manual error, minimal supervision and reduced human effort. Compact XL will be available for pre-ordering starting from 13th of this month.
 
Adar Poonawalla, CEO of the Serum Institute of India (SII), who unveiled the machine, said that Scientific and technological breakthroughs are driving our fight against Covid-19. This revolutionary product, with multiple patents already filed, will be a giant leap in making testing accessible. It will eliminate traditional barriers to the adoption of molecular diagnostics at labs and address any potential demand-supply gaps of highly skilled technicians for testing.
 
Abhijeet Pawar, Chairman, AP Globale, said that an important lesson Covid has taught us, to be self-reliant. He said, their focus is to drive social change through innovation.

   Related News

Live Twitter Feed

Listen News

Morning News 18 (Jan) Midday News 18 (Jan) Evening News 17 (Jan) Hourly 18 (Jan) (1800hrs)
समाचार प्रभात 18 (Jan) दोपहर समाचार 18 (Jan) समाचार संध्या 17 (Jan) प्रति घंटा समाचार 18 (Jan) (1810hrs)
Khabarnama (Mor) 18 (Jan) Khabrein(Day) 18 (Jan) Khabrein(Eve) 17 (Jan)
Aaj Savere 18 (Jan) Parikrama 18 (Jan)

Listen Programs

Market Mantra 17 (Jan) Samayki 1 (Jan) Sports Scan 17 (Jan) Spotlight/News Analysis 17 (Jan) Employment News 18 (Jan) रोजगार समाचार 17 (Jan) World News 17 (Jan) Samachar Darshan 22 (Mar) Radio Newsreel 21 (Mar)
    Public Speak

    Country wide 12 (Mar) Surkhiyon Mein 17 (Jan) Charcha Ka Vishai Ha 11 (Mar) Vaad-Samvaad 17 (Mar) Money Talk 17 (Mar) Current Affairs 6 (Mar) Sanskrit Saptahiki 16 (Jan) North East Diary 17 (Jan)